New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
07:20 EDTNUVANuVasive called a name to own at William Blair
Following the company's investor meeting, William Blair calls NuVasive a name to own at current share levels. The firm expects the company's performance to improve going forward, starting in Q4.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
09:20 EDTNUVANuVasive upgraded to Outperform, expects strong 2H at Northland
As previously reported, Northland upgraded NuVasive to Outperform from Market Perform and raised its price target to $68 from $48. The firm expects 2H results to beat expectations and is a buyer ahead of Q3 results given strength in the U.S. spine market, operating performance, and leverage. Northland views the iGA platform as a "game changer" and checks show NuVasive continues to take market share.
07:44 EDTNUVANuVasive price target raised to $65 from $57 at Leerink
Leerink raised its price target for NuVasive to $65 saying the margin improvement story "has legs" following the company's Q2 results. The firm reiterates an Outperform rating on the stock.
07:22 EDTNUVANuVasive upgraded to Outperform from Market Perform at Northland
July 28, 2015
16:31 EDTNUVANuVasive reaches definitive agreement with U.S. DOJ
Subscribe for More Information
16:20 EDTNUVANuVasive raises 2015 EPS outlook to $1.17 from $1.10, consensus $1.12
Sees 2015 revenue $810M, consensus $812.22M.
16:19 EDTNUVANuVasive reports Q2 EPS 31c, consensus 25c
Subscribe for More Information
16:18 EDTNUVANuVasive enters $13.5M settlement of Justice Department
NuVasive announced that it has reached a definitive settlement with the U.S. Department of Justice related to the subpoena issued to the company by the Office of Inspector General of the Department of Health and Human Services in 2013. NuVasive admits no wrongdoing as part of the settlement. On April 29, the company announced that it had reached an agreement in principle to settle the investigation with the DOJ. The company has now entered into a definitive settlement agreement with the United States, acting through DOJ and on behalf of OIG, the Defense Health Agency, the Office of Personnel Management, and the U.S. Department of Veteran Affairs. Under the terms of the settlement agreement, the company will pay $13.5M, plus fees and accrued interest. The settlement is neither an admission of liability or wrongdoing by the company nor a concession by the United States that its claims are not well founded. The company was not required to enter into a corporate integrity agreement by the OIG as part of the settlement.
15:21 EDTNUVANotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use